메뉴 건너뛰기




Volumn 18, Issue 7, 2016, Pages 786-795

Effects of intravenous iron therapy in iron-deficient patients with systolic heart failure: a meta-analysis of randomized controlled trials

Author keywords

Anaemia; Heart failure; Intravenous iron; Iron deficiency; Meta analysis; Outcomes

Indexed keywords

FERRIC CARBOXYMALTOSE; FERROUS SULFATE; IRON SACCHARATE; PLACEBO;

EID: 84979019763     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1002/ejhf.473     Document Type: Review
Times cited : (280)

References (43)
  • 10
    • 84859059635 scopus 로고    scopus 로고
    • Iron supplementation for the treatment of chronic heart failure and iron deficiency: systematic review and meta-analysis
    • Avni T, Leibovici L, Gafter-Gvili A. Iron supplementation for the treatment of chronic heart failure and iron deficiency: systematic review and meta-analysis. Eur J Heart Fail 2012;14:423–429.
    • (2012) Eur J Heart Fail , vol.14 , pp. 423-429
    • Avni, T.1    Leibovici, L.2    Gafter-Gvili, A.3
  • 11
    • 84876743344 scopus 로고    scopus 로고
    • Outcomes of patients with chronic heart failure and iron deficiency treated with intravenous iron: a meta-analysis
    • Kapoor M, Schleinitz MD, Gemignani A, Wu WC. Outcomes of patients with chronic heart failure and iron deficiency treated with intravenous iron: a meta-analysis. Cardiovasc Hematol Disord Drug Targets 2013;13:35–44.
    • (2013) Cardiovasc Hematol Disord Drug Targets , vol.13 , pp. 35-44
    • Kapoor, M.1    Schleinitz, M.D.2    Gemignani, A.3    Wu, W.C.4
  • 12
    • 84888073074 scopus 로고    scopus 로고
    • Relation of respiratory muscle strength, cachexia and survival in severe chronic heart failure
    • Habedank D, Meyer FJ, Hetzer R, Anker SD, Ewert R. Relation of respiratory muscle strength, cachexia and survival in severe chronic heart failure. J Cachexia Sarcopenia Muscle 2013;4:277–285.
    • (2013) J Cachexia Sarcopenia Muscle , vol.4 , pp. 277-285
    • Habedank, D.1    Meyer, F.J.2    Hetzer, R.3    Anker, S.D.4    Ewert, R.5
  • 18
    • 35248870765 scopus 로고    scopus 로고
    • Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency
    • Toblli JE, Lombraña A, Duarte P, Di Gennaro F. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency. J Am Coll Cardiol 2007;50:1657–1665.
    • (2007) J Am Coll Cardiol , vol.50 , pp. 1657-1665
    • Toblli, J.E.1    Lombraña, A.2    Duarte, P.3    Di Gennaro, F.4
  • 21
    • 70350567772 scopus 로고    scopus 로고
    • A pilot evaluation of the long-term effect of combined therapy with intravenous iron sucrose and erythropoietin in elderly patients with advanced chronic heart failure and cardio-renal anemia syndrome: influence on neurohormonal activation and clinical outcomes
    • Comín-Colet J, Ruiz S, Cladellas M, Rizzo M, Torres A, Bruguera J. A pilot evaluation of the long-term effect of combined therapy with intravenous iron sucrose and erythropoietin in elderly patients with advanced chronic heart failure and cardio-renal anemia syndrome: influence on neurohormonal activation and clinical outcomes. J Card Fail 2009;15:727–735.
    • (2009) J Card Fail , vol.15 , pp. 727-735
    • Comín-Colet, J.1    Ruiz, S.2    Cladellas, M.3    Rizzo, M.4    Torres, A.5    Bruguera, J.6
  • 24
    • 0034922729 scopus 로고    scopus 로고
    • EQ-5D: a measure of health status from the EuroQol Group
    • Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med 2001;33:337–343.
    • (2001) Ann Med , vol.33 , pp. 337-343
    • Rabin, R.1    de Charro, F.2
  • 25
    • 0034039691 scopus 로고    scopus 로고
    • Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure
    • Green CP, Porter CB, Bresnahan DR, Spertus JA. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. J Am Coll Cardiol 2000;35:1245–1255.
    • (2000) J Am Coll Cardiol , vol.35 , pp. 1245-1255
    • Green, C.P.1    Porter, C.B.2    Bresnahan, D.R.3    Spertus, J.A.4
  • 26
    • 84971242992 scopus 로고
    • Patients' self-assessment of their congestive heart failure, part 2: content, reliability and validity of a new measure, the Minnesota Living with Heart Failure Questionnaire
    • Rector TS, Kubo SH, Cohn JN. Patients' self-assessment of their congestive heart failure, part 2: content, reliability and validity of a new measure, the Minnesota Living with Heart Failure Questionnaire. Heart Fail 1987;198–209.
    • (1987) Heart Fail , vol.198-209
    • Rector, T.S.1    Kubo, S.H.2    Cohn, J.N.3
  • 29
    • 0037098199 scopus 로고    scopus 로고
    • Quantifying heterogeneity in a meta-analysis
    • Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539–1558.
    • (2002) Stat Med , vol.21 , pp. 1539-1558
    • Higgins, J.P.1    Thompson, S.G.2
  • 31
    • 0014384810 scopus 로고
    • Report of a WHO scientific group
    • Nutritional anaemias. Report of a WHO scientific group. World Health Organ Tech Rep Ser 1968;405:5–37.
    • (1968) World Health Organ Tech Rep Ser , vol.405 , pp. 5-37
  • 39
    • 84978983816 scopus 로고    scopus 로고
    • Clinical trials update from the European Society of Cardiology meeting 2014: PARADIGM-HF, CONFIRM-HF, SIGNIFY, atrial fibrillation, beta-blockers and heart failure, and vagal stimulation in heart failure
    • Clark AL, Pellicori P. Clinical trials update from the European Society of Cardiology meeting 2014: PARADIGM-HF, CONFIRM-HF, SIGNIFY, atrial fibrillation, beta-blockers and heart failure, and vagal stimulation in heart failure. ESC Heart Fail 2014;1:82–86.
    • (2014) ESC Heart Fail , vol.1 , pp. 82-86
    • Clark, A.L.1    Pellicori, P.2
  • 41
    • 0025100849 scopus 로고
    • The existence of publication bias and risk factors for its occurrence
    • Dickersin K. The existence of publication bias and risk factors for its occurrence. JAMA 1990;263:1385–1389.
    • (1990) JAMA , vol.263 , pp. 1385-1389
    • Dickersin, K.1
  • 42
    • 17944391767 scopus 로고
    • Intravenous iron-dextran: therapeutic and experimental possibilities
    • Ganzoni AM. Intravenous iron-dextran: therapeutic and experimental possibilities. Schweiz Med Wochenschr 1970;100:301–303.
    • (1970) Schweiz Med Wochenschr , vol.100 , pp. 301-303
    • Ganzoni, A.M.1
  • 43
    • 68049122102 scopus 로고    scopus 로고
    • Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement
    • Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. PLoS Med 2009;6:e1000097.
    • (2009) PLoS Med , vol.6
    • Moher, D.1    Liberati, A.2    Tetzlaff, J.3    Altman, D.G.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.